Journal profile · Dermatology
Journal of Investigative Dermatology
ISSN 0022-202X · eISSN 1523-1747 · ELSEVIER · UNITED STATES · Monthly · Founded 1938
Journal of Investigative Dermatology: CAS Zone 2 · Medicine (2025 upgraded edition); impact factor 6.69; hybrid open access; APC about USD 3,800; median 139 days to acceptance (144 articles, last 24 months); community-reported acceptance: about 25%; 2,810 articles in 2025; indexed in SCIE and Scopus.
Scope
Aims, scope and focus
Journal of Investigative Dermatology is published by ELSEVIER and is in Zone 2 of Medicine in the CAS Journal Ranking (2025 upgraded edition). By OpenAlex counts of its recent articles, its largest topics are Dermatology and Skin Diseases, Skin and Cellular Biology Research and Skin Protection and Aging, together about 27.4% of its articles. (generated from OpenAlex topic counts and CAS ranking data)
The Journal of Investigative Dermatology (JID) publishes high impact reports describing original research related to all aspects of cutaneous biology and skin disease. Descriptions of important findings that result from basic, translational, or clinical research are appropriate for submission. Clinical research can include, but is not limited to, interventional trials, genetic studies, epidemiology, and health services research. The JID places a high priority on publication of new insights into basic cutaneous biology, disease pathogenesis, and treatment. Reports that describe a new methodology, technique, or tool in combination with mechanistic insights into the problem that is being investigated are encouraged. It is possible that occasional descriptions of novel technology, methodology, or resources that are of special interest or utility to JID readers could be competitive for publication, even in the absence of new mechanistic insights. Reports describing novel variants in known genes with no new mechanistic data will not be reviewed. Case reports or case series, unless they provide new biologic insights, are rarely appropriate for submission. Purely hypothesis generating clinical research such as analysis of case reports, pharmacovigilance reports (for example, analyses of FAERS), unless truly novel, or accompanied with hypothesis testing approaches (e.g., cohort, case-control, clinical trial, and/or mechanistic laboratory studies) are not within the JID Scope. Clinical research using administrative claims or electronic medical record data (for example, TriNetX) should have evidence that the codes validly represent the variables being studied and that the data are complete enough to yield valid inferences.Standard features of the Journal include Original Articles, Review Articles, and Letters to the Editor. Perspectives and Commentaries are invited by the Editorial Board. All articles are peer reviewed prior to acceptance and publication, and some invited articles may ultimately not be accepted for publication. Online features enhance JID content, making it more relevant and accessible, especially to non-scientists, trainees, and clinician-educators.
From the journal's Aims & Scope
Research area (LetPub): Dermatology
Editor-in-chief Erwin TschachlerPublisher website
Editorial board by country: 9 in mainland China (about 8%); most named United States 45, Germany 16, Austria 10, Mainland China 9, United Kingdom 8 (115 members with a country) Editorial board ↗Publisher website ·
Main research topics OpenAlex counts of recent articles; shares are approximate
- Dermatology and Skin DiseasesMedicine11.5%
- Skin and Cellular Biology ResearchBiochemistry, Genetics and Molecular Biology7.9%
- Skin Protection and AgingMedicine7.9%
- Psoriasis: Treatment and PathogenesisImmunology and Microbiology5.9%
- Autoimmune Bullous Skin DiseasesMedicine5.9%
- melanin and skin pigmentationBiochemistry, Genetics and Molecular Biology5.8%
- Hair Growth and DisordersMedicine4.8%
- Immunotherapy and Immune ResponsesImmunology and Microbiology4.3%
Rankings & indexing
CAS ranking and database indexing
CAS Journal Ranking
CAS Journal Ranking, upgraded edition (March 2025)Medicine Zone 2
| Level | Category | Zone |
|---|---|---|
| Major | Medicine | Zone 2 |
| Minor | Dermatology | Zone 2 |
Top journal: noReview journal: no
CAS Xinrui Journal Ranking (March 2026)Medicine Zone 2
| Level | Category | Zone |
|---|---|---|
| Major | Medicine | Zone 2 |
| Minor | Dermatology | Zone 2 |
Top journal: noReview journal: not marked
CAS Journal Ranking, previous upgraded edition (December 2023)Medicine Zone 2
| Level | Category | Zone |
|---|---|---|
| Major | Medicine | Zone 2 |
| Minor | Dermatology | Zone 2 |
Top journal: yesReview journal: no
Database indexing
SCIEScopusLetPub
International journal early-warning lists: not listed in any editionLetPub
Editions, and major and minor categories, are shown separately and never merged into one zone; check which edition your institution uses before you submit or report.
Metrics
Impact metrics and publication volume
Impact
- Impact factor
- 6.69LetPub ·
- Impact factor (publisher)
- 7Publisher website ·
- CiteScore 2026-06
- 8.2LetPub ·
- CiteScore (publisher)
- 8.2Publisher website ·
- SJR 2026-06
- 1.72LetPub ·
- SNIP 2026-06
- 1.27LetPub ·
- h-index
- 181LetPub ·
- h-index
- 313OpenAlex ·
- i10-index
- 17,086OpenAlex ·
- 2-year mean citedness
- 0.73OpenAlex ·
- Self-citation rate
- 4.3%LetPub ·
- Share of gold OA articles
- 28.79%LetPub ·
Volume
- Articles per year
- 209LetPub ·
Articles by year OpenAlex count · 45,832 in total · the current year is incomplete
| Year | Articles | Open access | Citations |
|---|---|---|---|
| 2026 | 1,731 | 572 | 119 |
| 2025 | 2,810 | 2,172 | 1,345 |
| 2024 | 2,120 | 1,978 | 3,423 |
| 2023 | 2,521 | 2,521 | 4,557 |
| 2022 | 2,098 | 2,098 | 5,360 |
| 2021 | 1,748 | 1,748 | 10,910 |
Sources count differently and were observed at different times, so each source's own value is kept; "publisher" marks figures from the journal's website.
Review & acceptance
Review time and acceptance
Review time from article dates manuscript dates registered with PubMed · to
139 daysMedian, submission to acceptance · P25–P75 79 days – 232 days
- Acceptance to online
- median 30 days (144 articles)
- Submission to online
- median 163 days
- Sample
- 144 articles with submission and acceptance dates (1,034 in the window); the latest was accepted on
Only articles that were accepted and published are counted, not the time spent on rejected manuscripts, so this usually runs longer than a publisher's "time to first decision".
Other sources
- Average review time (community reports)
- about 2 monthsLetPub ·
- Average acceptance (community reports)
- 25%LetPub ·
- Peer review
- Single anonymous peer reviewPublisher website
Community reports come from authors' own submissions (confidence 0.5) and are not a promise from the journal; for publisher figures, the journal's own definitions apply.
Fees & open access
APC and open-access policy
Hybrid open accessLetPub
A subscription journal in which authors can pay to publish their article open access.
| Source | APC | Fee waiver | License | Observed |
|---|---|---|---|---|
| OpenAlex | USD 3,800 / EUR 3,550 / GBP 3,040 / JPY 471,310 | — | — | |
| Publisher website | USD 2,000 | — | — |
A hybrid journal charges the APC only when the author chooses open access; publishing under the subscription model is usually free.
Other charges and waivers (author guidelines)
- Submission fee
- USD 50
The journal's website is authoritative for fees; sources were observed at different times and each keeps its own value, without averaging.
Submission
Article types and submission policies (journal website)
What to prepare4 items from the author guidelines
- Reference style
- Author–date
- Suggested reviewers
- Optional
- Graphical abstract
- Optional
- Cover letter
- Optional
Article types accepted5
- letterBelow please find requirements, and suggested word, figure, and reference limits for articles submitted to JID. Word limits exclude the abstract, references, fi…Length not stated
- letter to the editorBelow please find requirements, and suggested word, figure, and reference limits for articles submitted to JID. Word limits exclude the abstract, references, fi…Length not stated
- original articleBelow please find requirements, and suggested word, figure, and reference limits for articles submitted to JID. Word limits exclude the abstract, references, fi…Length not stated
- original researchBelow please find requirements, and suggested word, figure, and reference limits for articles submitted to JID. Word limits exclude the abstract, references, fi…Length not stated
- review articleComprehensive, scholarly, and balanced, presenting an expert curation of the literature in the topic of interest. Consult the Editor at [email protected] before…Length not stated
Policy excerpts from the journal's websiteAI use, Authorship, Conflicts of interest, Data availability, Open access, Peer review, Self-archiving, Trial registration / reporting guidelines
- AI use Declaration of generative AI use
Authors must declare the use of generative AI tools in the manuscript preparation process upon submission of the paper.Generative AI and AI-assisted technologies (“AI tools”) have been rapidly adopted in research and scholarly publishing, offering significant benefits while requiring clear standards for responsible and transparent use.Authors preparing a manuscript for this journal may use AI tool…
Source ↗Publisher website ·- Authorship Authorship Conditions
JID ascribes to the authorship guidelines described in the The Uniform Requirements for Manuscripts Submitted to Biomedical Journals, by the International Committee of Medical Journal Editors. Briefly, each author should have participated sufficiently in the intellectual content of the work to take public responsibility for appropriate portions of its content. Authorship credit should be based on:…
Source ↗Publisher website ·- Conflicts of interest Conflict of Interest
Upon submission, the corresponding author will receive a unique link to an online form on which they will be asked to attest to 1) the accuracy of the author list and the authorship qualifications of all listed authors and 2) the accurate reporting of all author conflicts of interest within the submitted manuscript. More information on conflict of interest can be found in The Uniform Requirements …
Source ↗Publisher website ·- Data availability Data Availability Statement
The Editors seek to facilitate research progress, allow for reproducibility of results, and enhance replicability of findings in published research. To that end, primary research data should be made available free of charge to all researchers, whenever possible, and with minimal reuse restrictions. All submissions must include a "Data Availability Statement" that describes the availability of the …
Source ↗Publisher website ·- Open access Open access
Please visit our Open Access page for more information about open access publishing in this journal.Authors of research articles can choose to pay an article processing charge to publish their accepted articles open access (i.e., free to all readers, regardless of whether they have a subscription) online immediately upon publication. Please note that the open access article processing charge is in…
Source ↗Publisher website ·- Peer review Peer Review
All articles are peer reviewed prior to acceptance and publication Model summary
JID employs ScholarOne Manuscripts to conduct single-anonymized peer review (the identity of peer reviewers is kept confidential). Authors may suggest the invitation or exclusion of up to four reviewers at the time of submission. The journal will take these recommendations into consideration; however, the final decision regarding reviewers lies with the Editor. Submissions that will not be fully p…
Source ↗Publisher website ·- Self-archiving Embargo Policy
All articles accepted for publication in JID are embargoed until the date of online publication.For Original Articles and Letters to the Editor, both of which are published online before copyediting and typesetting, the following guidelines apply. The publication of the accepted manuscript online is an official publication of a JID article. It is a .pdf of the accepted version of an article, befor…
Source ↗Publisher website ·- Trial registration / reporting guidelines Reporting Guidelines:
Specific categories are preferred over collective terms, when possible. Authors should report the specific categories used in their studies and recognize that these categories will differ based on the databases or surveys used, the requirements of funders, and the geographic location of data collection or study participants. Categories included in groups labeled as “other” should be defined. Categ…
Source ↗Publisher website ·
Excerpts are quoted from the journal's website; "model summary" lines are written by Workers AI and checked against the text. The journal's website is authoritative.
Profile
Publication details and official links
- Publisher
- ELSEVIER
- Country or region
- UNITED STATES
- Language
- English
- Frequency
- Monthly
- Founded
- 1938
- ISSN
- 0022-202X
- Electronic ISSN
- 1523-1747
- Official links
- Journal homepage ↗LetPub
- Submission system ↗LetPub
- Author guidelines ↗LetPub
- Special issues ↗Publisher website
FAQ
Frequently asked questions about Journal of Investigative Dermatology
What CAS zone is Journal of Investigative Dermatology in?
In the 2025 upgraded edition of the CAS Journal Ranking, Journal of Investigative Dermatology is in Zone 2 of Medicine, and in Zone 2 of the minor category Dermatology. In the 2026 Xinrui edition it is in Zone 2 of Medicine. Zones from different editions, and from major and minor categories, are not interchangeable.
What is the impact factor of Journal of Investigative Dermatology?
The latest impact factor listed by LetPub is 6.69; CiteScore 8.2, h-index 313.
How long does peer review take at Journal of Investigative Dermatology?
Based on the dates recorded on 144 articles published between October 2024 and October 2026 (the last 24 months), the median time from submission to acceptance is 139 days (interquartile range 79–232 days); authors report an average review time of about 2 months; the community-reported acceptance is “about 25%”. Article statistics cover accepted papers only, publisher figures follow the journal's own definitions, and community reports come from authors' own submissions; none is a promise from the journal.
What are the manuscript requirements of Journal of Investigative Dermatology?
According to the journal's author guidelines: Reference style: Author–date; Suggested reviewers: Optional; Graphical abstract: Optional; Cover letter: Optional. A model extracted these from the author guidelines and each was checked against the text; check the latest version on the journal's website before submitting.
Where are the editorial board members of Journal of Investigative Dermatology based?
Of the 115 board members whose country the journal's board page names, 9 (about 8%) are in mainland China; the countries named most often are United States (45), Germany (16) and Austria (10). Counted from the institutions listed on the board page; for reference only.
Which databases index Journal of Investigative Dermatology?
According to LetPub and DOAJ records, Journal of Investigative Dermatology is indexed in SCIE and Scopus.
Is Journal of Investigative Dermatology open access, and what is the APC?
Journal of Investigative Dermatology is a hybrid journal. For open-access publication: APC about USD 3,800.
Sources and updates
The facts on this page come from LetPub, OpenAlex, Publisher website; every figure is tagged with its source and the date it was observed, and conflicting values are kept per source. LetPub source page: view ↗ (archived 2026-08-25). Last updated: .